CTOs on the Move

GI Pathology PLLC

www.gipath.com

 
GI Pathology PLLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Memphis, TN. To find more information about GI Pathology PLLC, please visit www.gipath.com
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.gipath.com
  • 150 Collins St
    Memphis, TN USA 38112-3814
  • Phone: 901.526.7444

Executives

Name Title Contact Details

Similar Companies

Middle Peninsula-Northern Neck Community Services Board

The Middle Peninsula Northern Neck Community Services Board is a public, nonprofit organization providing services to meet the needs of individuals and their families who have problems associated with mental health, intellectual disabilities, substance abuse, and developmental disabilities. Services are provided to residents in the Middle Peninsula and Northern Neck, VA. This area includes the counties of Westmoreland, Richmond, Essex, Northumberland, Lancaster, Gloucester, Mathews, Middlesex King & Queen and King William. It also includes the Town of Colonial Beach and West Point.

Expression Pathology, Inc

Expression Pathology, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Gaithersburg, MD. To find more information about Expression Pathology, Inc, please visit www.expressionpathology.com

CardioVention

CardioVention is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Frontage Laboratories

Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries.